(Q79827160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Mani Keshtgarpour

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Arkadiusz Z Dudek

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

103-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C.

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Clinical translation of angiogenesis inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Vascular endothelial growth factors and angiogenesis in eye disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Cytokine profiles during infliximab monotherapy in psoriatic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

A study of the repeatability of the diagnosis of Dupuytren's contracture and its prevalence in the grampian region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

[Dupuytren contracture in North Germany. Epidemiological study of 500 cases]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

Vasoprotective VEGF as a candidate for prevention of recurrence of fibrotic diseases such as Dupuytren's contracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.01.003

10.1016/J.TRSL.2007.01.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320795%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference